Erlonat 150mg - Erlotinib Tablets

Price 3800.0 INR/ strip

Get a Price/Quote

MOQ : 1 Box

Erlonat 150mg - Erlotinib Tablets Specification

Origin
INDIA

Indication
EGFR-positive Non-Small Cell Lung Cancer (NSCLC) and pancreatic cancer

Dosage Form
Tablets

Salt Composition
Erlotinib Tablets

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
N/A

Fermentation Smell
Normal Smell

Enzymatic Activity
EGFR Tyrosine Kinase Inhibitor (TKI)

Storage Instructions
Store below 30 C in a cool, dry place; protect from moisture and light

Shelf Life
24 Months

Erlonat 150mg - Erlotinib Tablets Trade Information

Minimum Order Quantity
1 Box

FOB Port
DELHI

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Boxes Per Month

Delivery Time
5 Days

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
BOX

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
N/A

About Erlonat 150mg - Erlotinib Tablets

Erlonat 150mg Tablet is an anticancer medicine. Cancer is an abnormal and uncontrolled multiplication of cells within the body. It is used in the treatment of patients with advanced or metastatic non-small cell lung cancer.

Erlonat 150mg Tablet is given in combination with Gemcitabine to treat pancreas cancer at the metastatic stage. Administration of this medicine may lead to kidney and liver failure. The doctor will periodically monitor your kidney and liver function. Inform your physician if you have any clotting disorders or medicines taken for clotting disorders, as the Erlonat 150mg Tablet may increase the tendency to bleed.

Inform your physician if you develop pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine. You are advised not to smoke while treated with this medicine, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside.